PPARGC1A and diabetes mellitus: We demonstrated that PKM2 activation alleviated the aberrant glycolytic flux, decreased PGC-1α expression, and impaired FAO and mitochondrial metabolism and function in HG-treated RTECs and mice with diabetes.